Skip to Main Content

Paper Details

Adverse thrombo-embolic events with newer tyrosine kinase inhibitors: a call to action for better risk stratification and monitoring.
Eur J Prev Cardiol
0
2022
Author NameAffiliation
Neal L WeintraubMedical College of Georgia at Augusta University
  • 1 - 1

Datasets

Release 1.2